{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:04:30Z","timestamp":1787166270536,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-22792-3","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T03:21:33Z","timestamp":1746847293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiological features of hypertension in a high-altitude population in Tibet, China: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yue","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieru","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongji","family":"Zhaxi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quzhen","family":"Jimei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxia","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"issue":"9995","key":"22792_CR1","first-page":"801","volume":"386","author":"NR Poulter","year":"2015","unstructured":"Poulter NR, Prabhakaran D, Caulfield M. Hypertens Lancet. 2015;386(9995):801\u201312.","journal-title":"Hypertens Lancet"},{"issue":"4","key":"22792_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223\u201337.","journal-title":"Nat Rev Nephrol"},{"key":"22792_CR3","unstructured":"Global report on. Hypertension: the race against a silent killer. World Health Organ. https:\/\/iris.who.int\/handle\/10665\/372896"},{"issue":"9963","key":"22792_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and National age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385(9963):117\u201371.","journal-title":"Lancet"},{"issue":"10100","key":"22792_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"GBD Causes of Death Collaborators","year":"2017","unstructured":"GBD Causes of Death Collaborators. Global, regional, and National age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1151\u2013210.","journal-title":"Lancet"},{"issue":"9882","key":"22792_CR6","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0140-6736(13)61097-1","volume":"381","author":"G Yang","year":"2013","unstructured":"Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990\u20132010:findings from the global burden of disease study 2010. Lancet. 2013;381(9882):1987\u20132015.","journal-title":"Lancet"},{"issue":"10100","key":"22792_CR7","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0140-6736(17)31833-0","volume":"390","author":"GBD Mortality Collaborators","year":"2017","unstructured":"GBD Mortality Collaborators. Global, regional, and National under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1084\u2013150.","journal-title":"Lancet"},{"issue":"22","key":"22792_CR8","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","volume":"137","author":"Z Wang","year":"2018","unstructured":"Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of hypertension in China: results from the China hypertension survey,2012\u20132015. Circulation. 2018;137(22):2344\u201356.","journal-title":"Circulation"},{"issue":"1","key":"22792_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41371-017-0003-4","volume":"32","author":"FL Zhang","year":"2017","unstructured":"Zhang FL, Guo ZN, Xing YQ, Wu YH, Liu HY, Yang Y. Hypertension prevalence, awareness, treatment, and control in Northeast China: a population-based cross-sectional survey. J Hum Hypertens. 2017;32(1):54\u201365.","journal-title":"J Hum Hypertens"},{"issue":"10112","key":"22792_CR10","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","volume":"390","author":"J Lu","year":"2017","unstructured":"Lu J, Lu Y, Wang X, ,Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE million PersonsProject). Lancet. 2017;390(10112):2549\u201358.","journal-title":"Lancet"},{"issue":"1","key":"22792_CR11","doi-asserted-by":"publisher","first-page":"19098","DOI":"10.1038\/s41598-019-55438-7","volume":"9","author":"X-B Huang","year":"2019","unstructured":"Huang X-B, Zhang Y, Wang T-D, Liu JX, Yi YJ, Liu Y, et al. Prevalence, awareness, treatment, and control of hypertension in Southwestern China. Sci Rep. 2019;9(1):19098.","journal-title":"Sci Rep"},{"key":"22792_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2147\/IJGM.S267346","volume":"13","author":"L Liu","year":"2020","unstructured":"Liu L, Chen C-L, Lo K, Huang JY, Yu YL, Huang YQ, et al. Trends of the status of hypertension in Southern China, 2012\u20132019. Int J Gen Med. 2020;13:599\u2013608.","journal-title":"Int J Gen Med"},{"issue":"13","key":"22792_CR13","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1136\/heartjnl-2014-307158","volume":"101","author":"C Mingji","year":"2015","unstructured":"Mingji C, Onakpoya IJ, Perera R, Ward AM, Heneghan CJ. Relationship between altitude and the prevalence of hypertension in Tibet: a systematic review. Heart. 2015;101(13):1054\u201360.","journal-title":"Heart"},{"issue":"14","key":"22792_CR14","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3390\/ijerph19148787","volume":"19","author":"W Peng","year":"2022","unstructured":"Peng W, Li K, Yan AF, Shi Z, Zhang J, Cheskin LJ, et al. Prevalence, management, and associated factors of obesity, hypertension, and diabetes in Tibetan population compared with China overall. Int J Environ Res Public Health. 2022;19(14):8787.","journal-title":"Int J Environ Res Public Health"},{"key":"22792_CR15","unstructured":"Tibet Autonomous Region Bureau of Statistics & Tibet Autonomous Region Seventh National Population Census Leading Group Office. (2021). Main Data Bulletin of the Seventh National Population Census of Tibet Autonomous Region. https:\/\/tjj.xizang.gov.cn\/xxgk\/tjxx\/tjgb\/202105\/t20210520_202889.html (Accessed date: 25 March 2025)."},{"issue":"1","key":"22792_CR16","doi-asserted-by":"publisher","first-page":"e010200","DOI":"10.1136\/bmjopen-2015-010200","volume":"6","author":"J Lu","year":"2016","unstructured":"Lu J, Xuan S, Downing NS, Wu C, Li L, Krumholz HM, et al. Protocol for the China PEACE (Patient-centered evaluative assessment of cardiac Events) million persons project pilot. BMJ Open. 2016;6(1):e010200.","journal-title":"BMJ Open"},{"key":"22792_CR17","unstructured":"Liu L. 2018 Chinese guidelines for the management of hypertension. Chin J Cardiovasc Med 2019;24 (1):24\u201356."},{"issue":"10","key":"22792_CR18","first-page":"833","volume":"44","author":"Joint Committee for the Revision of Chinese Guidelines for the Prevention","year":"2016","unstructured":"Joint Committee for the Revision of Chinese Guidelines for the Prevention. Treatment of dyslipidemia in adults. Chinese guidelines for the prevention and treatment of dyslipidemia in adults (2016 revised Edition). Chin J Cardiol. 2016;44(10):833\u201353.","journal-title":"Chin J Cardiol"},{"issue":"10027","key":"22792_CR19","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","volume":"387","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513\u201330.","journal-title":"Lancet"},{"issue":"1","key":"22792_CR20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/1753-0407.12609","volume":"10","author":"Chinese Medical Association Diabetes Branch","year":"2018","unstructured":"Chinese Medical Association Diabetes Branch. Guidelines for prevention and treatment of type 2 diabetes in China (2017 Edition). Chin J Diabetes. 2018;10(1):4\u201367.","journal-title":"Chin J Diabetes"},{"issue":"3","key":"22792_CR21","first-page":"245","volume":"15","author":"B-F Zhou","year":"2002","unstructured":"Zhou B-F. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases\u2013report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15(3):245\u201352.","journal-title":"Biomed Environ Sci"},{"issue":"9","key":"22792_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"310","author":"CK Chow","year":"2013","unstructured":"Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959\u201368.","journal-title":"JAMA"},{"issue":"3","key":"22792_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/HJH.0000000000002675","volume":"39","author":"J Li","year":"2021","unstructured":"Li J. Severe hypertension in China: results from the China PEACE million persons project. J Hypertens. 2021;39(3):461\u201370.","journal-title":"J Hypertens"},{"issue":"3","key":"22792_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/HYPERTENSIONAHA.118.11140","volume":"72","author":"O Narvaez-Guerra","year":"2018","unstructured":"Narvaez-Guerra O, Herrera-Enriquez K, Medina-Lezama J, Chirinos JA. Systemic hypertension at high altitude. Hypertension. 2018;72(3):567\u201378.","journal-title":"Hypertension"},{"issue":"6","key":"22792_CR25","doi-asserted-by":"publisher","first-page":"e0129966","DOI":"10.1371\/journal.pone.0129966","volume":"10","author":"S Xu","year":"2015","unstructured":"Xu S, Jiayong Z, Li B, Zhu H, Chang H, Shi W, et al. Prevalence and clustering of cardiovascular disease risk factors among Tibetan adults in China: A Population-Based study. PLoS ONE. 2015;10(6):e0129966.","journal-title":"PLoS ONE"},{"issue":"10","key":"22792_CR26","doi-asserted-by":"publisher","first-page":"e110131","DOI":"10.1371\/journal.pone.0110131","volume":"9","author":"X Zhao","year":"2014","unstructured":"Zhao X, Yin X, Li X, Yan LL, Lam CT, Li S, et al. Using a low-sodium, high-potassium salt substitute to reduce blood pressure among Tibetans with high blood pressure: a patient-blinded randomized controlled trial. PLoS ONE. 2014;9(10):e110131.","journal-title":"PLoS ONE"},{"key":"22792_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ajh.2012.9","volume":"25","author":"X Zhao","year":"2012","unstructured":"Zhao X, Li S, Ba S, et al. Prevalence, awareness, treatment, and control of hypertension among herdsmen living at 4,300 m in Tibet. Am J Hypertens. 2012;25:583\u20139.","journal-title":"Am J Hypertens"},{"issue":"10112","key":"22792_CR28","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/S0140-6736(17)33109-4","volume":"390","author":"X Li","year":"2017","unstructured":"Li X, Lu J, Hu S, Cheng KK, De Maeseneer J, Meng Q, et al. The primary healthcare system in China. Lancet. 2017;390(10112):2584\u201394.","journal-title":"Lancet"},{"issue":"1","key":"22792_CR29","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S2214-109X(22)00428-4","volume":"11","author":"T Zhou","year":"2023","unstructured":"Zhou T, Wang Y, Zhang H, Wu C, Tian N, Cui J, et al. Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million persons project and primary health-care survey: a cross-sectional study. Lancet Glob Health. 2023;11(1):e83\u201394.","journal-title":"Lancet Glob Health"},{"key":"22792_CR30","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH et al. \/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71 (6):e13-e115.","DOI":"10.1161\/HYP.0000000000000065"},{"issue":"10","key":"22792_CR31","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. Authors\/Task force members. 2018 ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension. J Hypertens. 2018;36(10):1953\u20132041.","journal-title":"J Hypertens"},{"key":"22792_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/PPA.S18481","volume":"5","author":"KV Nair","year":"2011","unstructured":"Nair KV, Belletti DA, Doyle JJ, Allen RR, McQueen RB, Saseen JJ, et al. Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey. Patient Prefer Adherence. 2011;5:195\u2013206.","journal-title":"Patient Prefer Adherence"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22792-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22792-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22792-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T16:03:44Z","timestamp":1746893024000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22792-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22792"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22792-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5431755\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Fuwai Hospital, Chinese Academy of Medical Sciences (approval number: 2014\u2009\u2212\u2009574). All participants provided written informed consent before participating in the study. All procedures were in accordance with the Declaration of Helsinki (1964).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patients and\/or the public were not involved in the design,  conduct, reporting, or dissemination plans of this research.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}}],"article-number":"1729"}}